Potassium-Sparing Diuretics Market - Top Companies and Manufacturers

Companies Dominating the Potassium-Sparing Diuretics Landscape

Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Merck Sharp & Dohme Corp.
Accord Healthcare
Amneal Pharmaceuticals LLC
Centaur Pharmaceuticals Pvt. Ltd.
Validus Pharmaceuticals LLC
Teva Pharmaceutical Industries Ltd.
CMP Pharma
Boehringer Ingelheim GmbH
Bayer AG

Browse Key Market Insights with Data Illustration:

Potassium-Sparing Diuretics Market Size & Share, Growth Analysis 2036

In the News

A new FDA approval for Merck & Co., Inc., VERQUVO® (vericiguat) has been announced. heart failure (HF) hospitalization risk reduction with VERQUVO in adults with symptomatic chronic heart failure and a low ejection fraction (45%) after heart failure hospitalization or need for intravenous (IV) diuretics in adults.
In a joint announcement today, Boehringer Ingelheim GmbH and Eli Lilly and Company announced that Jadix® (empagliflozin) 10 mg has been approved by the U.S. Food and Drug Administration for the reduction of cardiovascular death and hospitalization associated with heart failure in adults with heart failure with reduced ejection fractions (HFrEF).

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of potassium-sparing diuretics is estimated at USD 111.32 Million.

The potassium-sparing diuretics market size was valued at USD 105.8 Million in 2023 and is likely to cross USD 220.19 Million by the end of 2036, registering more than 5.8% CAGR during the forecast period i.e., between 2024-2036. The growing prevalence of chronic diseases, such as hypertension and kidney diseases, and the increasing demand for better treatments are the major factors driving the market growth.

North America is expected to be the largest with a share of about 39% by 2036, propelled by increasing prevalence of cardiovascular diseases and the increasing demand for safe and effective medicines.

Pfizer Inc., Merck Sharp & Dohme Corp., Accord Healthcare, Amneal Pharmaceuticals LLC, Centaur Pharmaceuticals Pvt. Ltd., Validus Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., CMP Pharma, Boehringer Ingelheim GmbH, Bayer AG

Potassium-Sparing Diuretics Market - Top Companies and Manufacturers

Companies Dominating the Potassium-Sparing Diuretics Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the potassium-sparing diuretics market?

Why is the potassium-sparing diuretics sector gaining traction in near future?

Which region accounted for the largest potassium-sparing diuretics industry share?

Who are the major potassium-sparing diuretics players?